瘤类型不可知性,向性疗法向前迈出了一步:首次批准 HER2 向性治疗的瘤不可知性
Semir Vranic1, Zoran Gatalica2
1College of Medicine, QU Health, Qatar University, Doha, Qatar.
Biomolecules & biomedicine
|April 24, 2024
概括
精密瘤学正在转向针对各种癌症类型的特定分子生物标志物的瘤无关治疗方法. 这种方法使得瘤组织学无关的向治疗成为可能,改善了癌症护理.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 精准医学是一门精准的医学.
背景情况:
- 传统的癌症治疗方法通常是针对瘤的.
- 最近的进展使我们能够转向以分子为基础的,生物标志物驱动的疗法.
- 无瘤治疗方法代表了精密瘤学的范式转变.
研究的目的:
- 描述瘤学中瘤类型不可知药物的新方法.
- 突出分子生物标志物在指导癌症治疗中的作用.
- 解释这些药物是如何针对不同类型的癌症,基于共享的基因组变化.
主要方法:
- 利用具有不同瘤类型的小型临床队列.
- 在不同组织学中识别常见的基因组事件 (分子生物标志物).
- 分析生物标志物在预测药物反应和耐药性的作用.
主要成果:
- 瘤类型的不可知药物提供针对性的治疗,无论瘤组织学如何.
- 常见的分子生物标志物是确定这些疗法患者群体的关键.
- 生物标志物对于了解药物的有效性和潜在的耐药性机制至关重要.
结论:
- 无瘤疗法代表了精密瘤学的重大进步.
- 分子生物标志物对于这些向治疗的成功至关重要.
- 这种方法可以在不同类型的癌症中更广泛地应用有效的治疗方法.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Tumor Immunotherapy
520
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
520
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Cancer Vaccines
359
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
359


